Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ACUROTCMKTS:BETRFOTCMKTS:PKPHOTCMKTS:TOWTFOTCMKTS:WHCA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACURAcura Pharmaceuticals$0.00-92.0%$0.01$0.00▼$0.75$170K-2.41575 shs36,000 shsBETRFBetterLife Pharma$0.06+4.4%$0.07$0.05▼$0.15$7.86M1.4513,097 shs7,000 shsPKPHPeak Pharmaceuticals$1.08+6.1%$2.14$0.52▼$9.12$423K0.549,053 shs360 shsTOWTFTower One Wirls$0.00$0.00▼$0.00N/AN/AN/AN/AWHCAWilliston$0.00$0.00▼$0.00N/AN/AN/AN/ABeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACURAcura Pharmaceuticals0.00%0.00%-87.50%-87.37%-90.91%BETRFBetterLife Pharma0.00%-11.26%-20.65%+3.76%-24.13%PKPHPeak Pharmaceuticals0.00%-31.71%-0.25%-77.39%-53.75%TOWTFTower One Wirls0.00%0.00%0.00%0.00%0.00%WHCAWilliston0.00%0.00%0.00%0.00%-99.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationACURAcura PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/ABETRFBetterLife Pharma0.1919 of 5 stars0.03.00.00.00.01.70.0PKPHPeak PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/ATOWTFTower One WirlsN/AN/AN/AN/AN/AN/AN/AN/AWHCAWillistonN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACURAcura Pharmaceuticals 0.00N/AN/AN/ABETRFBetterLife Pharma 0.00N/AN/AN/APKPHPeak Pharmaceuticals 0.00N/AN/AN/ATOWTFTower One Wirls 0.00N/AN/AN/AWHCAWilliston 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACURAcura PharmaceuticalsN/AN/AN/AN/AN/AN/ABETRFBetterLife PharmaN/AN/AN/AN/A($0.04) per shareN/APKPHPeak PharmaceuticalsN/AN/AN/AN/AN/AN/ATOWTFTower One WirlsN/AN/AN/AN/AN/AN/AWHCAWillistonN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACURAcura PharmaceuticalsN/AN/A0.00∞N/AN/AN/AN/AN/ABETRFBetterLife Pharma-$2.55M-$0.02N/A∞N/AN/AN/A-564.83%N/APKPHPeak Pharmaceuticals-$160KN/A0.00∞N/AN/AN/A-159.55%N/ATOWTFTower One WirlsN/AN/A0.00N/AN/AN/AN/AN/AN/AWHCAWillistonN/AN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACURAcura PharmaceuticalsN/AN/AN/AN/AN/ABETRFBetterLife PharmaN/AN/AN/AN/AN/APKPHPeak PharmaceuticalsN/AN/AN/AN/AN/ATOWTFTower One WirlsN/AN/AN/AN/AN/AWHCAWillistonN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioACURAcura PharmaceuticalsN/AN/AN/ABETRFBetterLife PharmaN/A0.030.03PKPHPeak PharmaceuticalsN/A0.150.15TOWTFTower One WirlsN/AN/AN/AWHCAWillistonN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACURAcura PharmaceuticalsN/ABETRFBetterLife Pharma0.01%PKPHPeak PharmaceuticalsN/ATOWTFTower One WirlsN/AWHCAWillistonN/AInsider OwnershipCompanyInsider OwnershipACURAcura Pharmaceuticals20.20%BETRFBetterLife Pharma34.77%PKPHPeak Pharmaceuticals18.40%TOWTFTower One Wirls31.97%WHCAWillistonN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACURAcura Pharmaceuticals1066.50 million53.07 millionNot OptionableBETRFBetterLife Pharma7129.46 million84.45 millionNot OptionablePKPHPeak Pharmaceuticals1392,000320,000Not OptionableTOWTFTower One WirlsN/AN/AN/ANot OptionableWHCAWillistonN/AN/AN/ANot OptionablePKPH, WHCA, TOWTF, ACUR, and BETRF HeadlinesRecent News About These CompaniesNo headlines for this company have been tracked by MarketBeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePKPH, WHCA, TOWTF, ACUR, and BETRF Company DescriptionsAcura Pharmaceuticals OTCMKTS:ACUR$0.0002 0.00 (-92.00%) As of 09:30 AM EasternAcura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc. and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was formerly known as Halsey Drug Co., Inc. The company was incorporated in 1935 and is based in Palatine, Illinois. Acura Pharmaceuticals, Inc. operates as a subsidiary of Abuse Deterrent Pharma, LLC.BetterLife Pharma OTCMKTS:BETRF$0.06 +0.00 (+4.45%) As of 10:50 AM EasternBetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benzodiazepine dependency, anxiety, and neurodegenerative disorders. It is also developing MM-003, which has completed Phase II clinical trials for treatment of COVID-19 and other respiratory viral infections; and MM-001, a topical cream for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia that has completed Phase II clinical trials. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.Peak Pharmaceuticals OTCMKTS:PKPH$1.08 +0.06 (+6.14%) As of 06/30/2025Peak Pharmaceuticals, Inc. manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.Tower One Wirls OTCMKTS:TOWTFTower One Wireless Corp. owns, develops, and operates build-to-suit multitenant communications towers in Argentina, Colombia, Mexico, the United States, and internationally. It primarily engages in the leasing of space on communications sites to mobile network operators. The company also provides tower-related services, including site acquisition, zoning and permitting, structural analysis, and construction. Tower One Wireless Corp. was incorporated in 2005 and is headquartered in Bogotá, Colombia.Williston OTCMKTS:WHCAWilliston Holding Company, Inc. owns and operates restaurants. The company was incorporated in 2012 and is based in Eden Prairie, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 2 Reasons to Buy Trade Desk Stock Now and 1 Warning Sign Toast Stock: A Fast-Growing Mid-Cap Eyeing Further Upside Breakout Alert: Disney Stock Hits Multi-Year High 2 Under the Radar Space & Defense Stocks With Huge Potential Palantir’s $100M Nuclear OS Pact Boosts Bullish Case Forget IBM: Accenture’s AI Momentum Is Your Next Buy Joby Stock Soars as Piloted Flights in Dubai Signal a New Era Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
